Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Barts & The London NHS Trust
With
National Health Service, United Kingdom
The study population will comprise sheltered accommodation residents and staff fulfilling eligibility criteria. Half of the sheltered accommodation schemes will be randomly allocated to 2-monthly oral bolus vitamin D supplementation (Vigantol oil) over a period of one year, and half to placebo.
Participants will be followed for one year.
Age
16–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Permanent resident or member of staff at sheltered accommodation unit
If a woman of child-bearing potential, is sexually abstinent or has negative pregnancy test within 7 days of recruitment and agrees to use reliable form of contraception until she has completed the study
Able to give written informed consent to participate
Age ≥ 16 years on day of first dose of IMP
You may not be if
Current diagnosis of asthma or chronic obstructive pulmonary disease
Chronic upper or lower respiratory infection or other condition causing chronic cough
Condition requiring treatment with vitamin D at a dose of \> 10 micrograms vitamin D/day
Episode of upper or lower respiratory tract infection up to 28 days before first dose of IMP
Known sarcoidosis, hyperparathyroidism, nephrolithiasis, active tuberculosis, vitamin D intolerance, liver failure, renal failure, terminal illness, lymphoma or other malignancy not in remission at time of recruitment
